Company · CIK 1693011

# Inozyme Pharma, Inc.

| CIK | [1693011](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001693011) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-09-03 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-258702 | Shelf Effective | 2021-08-11 | 2025-07-01 | 6 |
| 333-275364 | Shelf Effective | 2023-11-07 | 2025-07-01 | 4 |
| 333-239648 | IPO Final prospectus | 2020-07-02 | 2020-07-24 | 6 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-07-01 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1693011/999999999525002117/9999999995-25-002117-index.htm) Declared effective | 333-275364 | 9999999995-25-002117 |
| 2025-07-01 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1693011/999999999525002110/9999999995-25-002110-index.htm) Declared effective | 333-258702 | 9999999995-25-002110 |
| 2024-08-06 | [424B5](https://www.sec.gov/Archives/edgar/data/1693011/000119312524194954/0001193125-24-194954-index.htm) Shelf takedown | 333-275364 | 0001193125-24-194954 |
| 2023-11-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1693011/999999999523003337/9999999995-23-003337-index.htm) Declared effective | 333-275364 | 9999999995-23-003337 |
| 2023-11-07 | [S-3](https://www.sec.gov/Archives/edgar/data/1693011/000119312523272415/0001193125-23-272415-index.htm) Shelf registered | 333-275364 | 0001193125-23-272415 |
| 2023-07-28 | [424B5](https://www.sec.gov/Archives/edgar/data/1693011/000119312523197820/0001193125-23-197820-index.htm) Shelf takedown | 333-258702 | 0001193125-23-197820 |
| 2023-07-27 | [424B5](https://www.sec.gov/Archives/edgar/data/1693011/000119312523196281/0001193125-23-196281-index.htm) Shelf takedown | 333-258702 | 0001193125-23-196281 |
| 2022-04-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1693011/000119312522105747/0001193125-22-105747-index.htm) Shelf takedown | 333-258702 | 0001193125-22-105747 |
| 2021-08-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1693011/999999999521003279/9999999995-21-003279-index.htm) Declared effective | 333-258702 | 9999999995-21-003279 |
| 2021-08-11 | [S-3](https://www.sec.gov/Archives/edgar/data/1693011/000119312521242618/0001193125-21-242618-index.htm) Shelf registered | 333-258702 | 0001193125-21-242618 |
| 2020-07-24 | [424B4](https://www.sec.gov/Archives/edgar/data/1693011/000119312520198533/0001193125-20-198533-index.htm) Final prospectus | 333-239648 | 0001193125-20-198533 |
| 2020-07-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1693011/999999999520001902/9999999995-20-001902-index.htm) Declared effective | 333-239648 | 9999999995-20-001902 |
| 2020-07-23 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1693011/000119312520197525/0001193125-20-197525-index.htm) Amendment | 333-239648 | 0001193125-20-197525 |
| 2020-07-22 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1693011/000119312520196740/0001193125-20-196740-index.htm) Amendment | 333-239648 | 0001193125-20-196740 |
| 2020-07-20 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1693011/000119312520195044/0001193125-20-195044-index.htm) Amendment | 333-239648 | 0001193125-20-195044 |
| 2020-07-02 | [S-1](https://www.sec.gov/Archives/edgar/data/1693011/000119312520186800/0001193125-20-186800-index.htm) Registration filed | 333-239648 | 0001193125-20-186800 |
| 2020-05-08 | [DRS](https://www.sec.gov/Archives/edgar/data/1693011/000095012320004197/0000950123-20-004197-index.htm) Draft made public | 377-03163 | 0000950123-20-004197 |

[All filings of this company](https://equitycapital.markets/filings?cik=1693011) · [CSV](https://equitycapital.markets/filings.csv?cik=1693011)

---
Source page: https://equitycapital.markets/company/1693011 · Data: U.S. SEC EDGAR · CC BY 4.0